FDA Clears Dermalogica PRO Pen Microneedling Device
The Class II medical device will be available in the US starting in 2026, marking the company's expansion into medical aesthetics.
The Class II medical device will be available in the US starting in 2026, marking the company's expansion into medical aesthetics.
The facility features a dedicated training space for healthcare professionals and supports the company’s long-term investment in the dermatology market.